Building with ARIA: Unlocking an Innovation Ecosystem

Join Nucleate UK and ARIA as we host an in-depth technical exploration of the ARIA Ecosystem; including the Activation Partners, Creators, and institutions. This event will be especially pertinent for any persons or organisations interested in Programme Director roles, or Activation Partners for Cohort 2!
How do we build high quality programmes that support breakthrough science and then translate that science?
ARIA was set up to catalyse technological breakthroughs that will dramatically improve the lives of everyone in society – that’s why we back scientists and engineers to pursue research that’s too ambitious, counterintuitive or underexplored to be supported elsewhere.
But breakthroughs alone aren’t enough. They require the right conditions to be translated into world-changing capabilities – conditions that ensure discovery doesn’t get stuck in a lab but makes widespread social and economic impact.
When exploring how we could make these conditions a core part of our model, we worked from three core hypotheses:
Activating talent: The UK possesses a deep well of latent entrepreneurial talent which can be activated to create global change through R&D, provided the right platforms.
Building ecosystems: The primary bottleneck to societally impactful breakthroughs in the UK isn’t a lack of incredible science, but the relative lack of an ecosystem that seamlessly bridges the gap between a ‘high-risk idea’ and a ‘scalable organisation’.
Lasting impact: ARIA’s funding could catalyse new types of translational support for frontier R&D in the UK and these could build enough self-sustaining momentum to outlive ARIA’s direct support.
The Advanced Research + Invention Agency (ARIA) is an R&D funding agency created to unlock technological breakthroughs that benefit everyone. This seminar will provide an inside look at ARIA and its Opportunity Spaces as we delve into the unparalleled value of investing in frontier research and discovery to drive groundbreaking innovation. ARIA was established in January 2023 to create transformational impact through science and technology. With £800 million in initial funding and unmatched autonomy and flexibility, ARIA is tackling global challenges with R&D. ARIA's Programme Directors are the driving force behind this vision, each entrusted with managing a £50 million+ budget to lead ambitious, high-risk, high-reward initiatives.
Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.org for more information, and visit https://nucleate.org/privacy-policy/ to read our privacy policy.
We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!
https://nucleate.org/sponsors/